| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease.
|
Sci Transl Med
|
2011
|
5.30
|
|
2
|
The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.
|
Adv Anat Pathol
|
2010
|
1.76
|
|
3
|
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
|
Mod Pathol
|
2012
|
1.52
|
|
4
|
The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation.
|
J Biol Chem
|
2011
|
1.31
|
|
5
|
HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.
|
Appl Immunohistochem Mol Morphol
|
2012
|
1.27
|
|
6
|
Diagnosis of pancreatic gastrointestinal stromal tumor by EUS guided FNA.
|
JOP
|
2008
|
1.16
|
|
7
|
Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.
|
Mod Pathol
|
2013
|
1.12
|
|
8
|
Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.
|
Genome Biol
|
2014
|
1.05
|
|
9
|
PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
|
Mod Pathol
|
2010
|
0.92
|
|
10
|
Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
|
Cancer Cytopathol
|
2012
|
0.91
|
|
11
|
Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.91
|
|
12
|
Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
|
Gastrointest Endosc
|
2013
|
0.90
|
|
13
|
Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
|
Am J Surg Pathol
|
2013
|
0.90
|
|
14
|
Signet ring cell colorectal carcinoma: a distinct subset of mucin-poor microsatellite-stable signet ring cell carcinoma associated with dismal prognosis.
|
Am J Surg Pathol
|
2013
|
0.90
|
|
15
|
A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas.
|
Mod Pathol
|
2011
|
0.89
|
|
16
|
Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
|
Am J Surg Pathol
|
2014
|
0.89
|
|
17
|
Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
|
Am J Surg Pathol
|
2015
|
0.87
|
|
18
|
Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
|
Am J Clin Oncol
|
2012
|
0.86
|
|
19
|
Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
|
Ann Surg Oncol
|
2012
|
0.86
|
|
20
|
A comparison of CMV detection in gastrointestinal mucosal biopsies using immunohistochemistry and PCR performed on formalin-fixed, paraffin-embedded tissue.
|
Am J Surg Pathol
|
2013
|
0.85
|
|
21
|
Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping.
|
Hum Pathol
|
2012
|
0.85
|
|
22
|
Isocitrate dehydrogenase-1 is mutated in inflammatory bowel disease-associated intestinal adenocarcinoma with low-grade tubuloglandular histology but not in sporadic intestinal adenocarcinoma.
|
Am J Surg Pathol
|
2014
|
0.84
|
|
23
|
Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.
|
Am J Surg Pathol
|
2009
|
0.84
|
|
24
|
Temporal progression of skeletal cystic angiomatosis.
|
Skeletal Radiol
|
2007
|
0.81
|
|
25
|
Pathologic continuum of acute appendicitis: sonographic findings and clinical management implications.
|
Ultrasound Q
|
2011
|
0.81
|
|
26
|
PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.
|
Cancer Cytopathol
|
2011
|
0.80
|
|
27
|
Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas.
|
Appl Immunohistochem Mol Morphol
|
2011
|
0.80
|
|
28
|
Colloid carcinoma of the pancreas.
|
Dig Dis Sci
|
2011
|
0.80
|
|
29
|
Lynch syndrome-associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach.
|
Hum Pathol
|
2013
|
0.80
|
|
30
|
The histopathology of PRSS1 hereditary pancreatitis.
|
Am J Surg Pathol
|
2014
|
0.79
|
|
31
|
Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms.
|
Am J Surg Pathol
|
2014
|
0.78
|
|
32
|
Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinoma.
|
Cancer
|
2010
|
0.77
|
|
33
|
Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
|
Am J Surg Pathol
|
2011
|
0.77
|
|
34
|
Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts.
|
BMC Gastroenterol
|
2012
|
0.77
|
|
35
|
Ruptured biliary cystadenoma managed by angiographic embolization and interval partial hepatectomy.
|
Dig Dis Sci
|
2011
|
0.76
|
|
36
|
MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
|
Am J Surg Pathol
|
2016
|
0.76
|
|
37
|
Spiral coronary dissection after percutaneous coronary intervention with retrograde propagation into the ascending aorta.
|
Cardiol Rev
|
2005
|
0.76
|
|
38
|
A Practical Approach to the Evaluation of Gastrointestinal Tract Carcinomas for Lynch Syndrome.
|
Am J Surg Pathol
|
2016
|
0.76
|
|
39
|
Diversion colitis in a 19-year-old female with megacystis-microcolon-intestinal hypoperistalsis syndrome.
|
Dig Dis Sci
|
2009
|
0.75
|
|
40
|
Reactive lymphoid hyperplasia of the terminal ileum: a benign (lymphoma-like) condition that may harbor aberrant immunohistochemical patterns or clonal immunoglobulin heavy chain gene rearrangements.
|
Appl Immunohistochem Mol Morphol
|
2014
|
0.75
|
|
41
|
Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease-associated Colorectal Dysplasia and Adenocarcinoma.
|
Am J Surg Pathol
|
2019
|
0.75
|
|
42
|
Noncorrelating Pap tests and cervical biopsies: histological predictors of subsequent correlation.
|
Diagn Cytopathol
|
2005
|
0.75
|
|
43
|
A Polyclonal Antibody to NKX3.1 Identifies Fungal Organisms From the Esophagus.
|
Appl Immunohistochem Mol Morphol
|
2017
|
0.75
|
|
44
|
Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 Deficiency.
|
Appl Immunohistochem Mol Morphol
|
2016
|
0.75
|
|
45
|
Histologic Features Do Not Reliably Predict Mismatch Repair Protein Deficiency in Colorectal Carcinoma: The Results of a 5-Year Prospective Evaluation.
|
Appl Immunohistochem Mol Morphol
|
2017
|
0.75
|
|
46
|
Colorectal carcinomas with submucosal invasion (pT1): analysis of histopathologic and molecular factors predicting lymph node metastasis.
|
Mod Pathol
|
2017
|
0.75
|